Upfront Ruxolitinib for Chronic Graft-vs-host Disease

Clinical trial NCT06695507 · TERMINATED

Trial details

NCT number: NCT06695507
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Graft Versus Host Disease

Start date: 2025-02-19
Primary completion: 2025-08-20
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.